What amount sold does FOXO TECHNOLOGIES INC. report in Form D filings?

The latest linked filings report $17.8M sold across 27 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was FOXO TECHNOLOGIES INC.'s most recent SEC filing?

FOXO TECHNOLOGIES INC.'s most recent Form D filing was on 2025-10-14.

How many investors does FOXO TECHNOLOGIES INC. have?

The most recent Form D filing lists 2 investor(s).

What type of securities does FOXO TECHNOLOGIES INC. offer?

FOXO TECHNOLOGIES INC.'s SEC Form D filings indicate equity offerings.

FOXO TECHNOLOGIES INC.

CIK: 0001812360·Hospitals and Physicians·WEST PALM BEACH, FL·Corporation

Reported Sold

$17,846,355

Total Filings

Identified Offerings

Last Filed

Oct 14, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Hospitals and Physicians industry

SEC EDGAR

Offering filing timeline

Oct 14, 2025Form D/A — Amendment

Reported sold: $3,500,000 · Target: $3,500,000

Rule 506(b)·2 investors·Section 4(a)(5)

Changed: Reported amount sold, Offering target

Oct 10, 2025Form D — New notice

Reported sold: $600,000 · Target: Indefinite

Rule 506(b)·2 investors·Section 4(a)(5)

Jun 20, 2025Form D — New notice

Reported sold: $1,650,000 · Target: $1,650,000

Rule 506(b)·1 investor·Section 4(a)(5)

Jun 2, 2025Form D — New notice

Reported sold: $550,000 · Target: $550,000

Rule 506(b)·1 investor·Section 4(a)(5)

May 22, 2025Form D — New notice

Reported sold: $550,000 · Target: $550,000

Rule 506(b)·1 investor·Section 4(a)(5)

Apr 21, 2025Form D — New notice

Reported sold: $325,000 · Target: $325,000

Rule 506(b)·1 investor·Section 4(a)(5)

Mar 24, 2025Form D — New notice

Reported sold: $110,000 · Target: $1,500,000

Rule 506(b)·2 investors·Section 4(a)(5)

Mar 21, 2025Form D/A — Amendment

Reported sold: $425,150 · Target: $1,650,000

Rule 506(b)·1 investor·Section 4(a)(5)

Changed: Reported amount sold, Offering target, Finders fees

Mar 7, 2025Form D — New notice

Reported sold: $98,900 · Target: $98,900

Rule 506(b)·2 investors·Section 4(a)(5)

Mar 3, 2025Form D — New notice

Reported sold: $55,000 · Target: $55,000

Rule 506(b)·2 investors·Section 4(a)(5)

Feb 20, 2025Form D — New notice

Reported sold: $120,000 · Target: $120,000

Rule 506(b)·2 investors·Section 4(a)(5)

Feb 11, 2025Form D — New notice

Reported sold: $110,000 · Target: $110,000

Rule 506(b)·2 investors·Section 4(a)(5)

Feb 5, 2025Form D — New notice

Reported sold: $150,650 · Target: $150,650

Rule 506(b)·2 investors·Section 4(a)(5)

Jan 22, 2025Form D — New notice

Reported sold: $291,500 · Target: $291,500

Rule 506(b)·1 investor·Section 4(a)(5)

Jan 13, 2025Form D — New notice

Reported sold: $100,000 · Target: $5,000,000

Rule 506(b)·1 investor·Section 4(a)(5)

Dec 4, 2024Form D — New notice

Reported sold: $220,000 · Target: $220,000

Rule 506(b)·2 investors·Section 4(a)(5)

Dec 4, 2024Form D — New notice

Reported sold: $220,000 · Target: $220,000

Rule 506(b)·2 investors·Section 4(a)(5)

Oct 29, 2024Form D — New notice

Reported sold: $40,533 · Target: $40,533

Rule 506(b)·1 investor·Section 4(a)(5)

Oct 28, 2024Form D — New notice

Reported sold: $256,500 · Target: $256,500

Rule 506(b)·1 investor·Section 4(a)(5)

Oct 23, 2024Form D — New notice

Reported sold: $121,900 · Target: $121,900

Rule 506(b)·1 investor·Section 4(a)(5)

Aug 9, 2024Form D — New notice

Reported sold: $235,435 · Target: Indefinite

Rule 506(b)·1 investor·Section 4(a)(5)

Aug 9, 2024Form D — New notice

Reported sold: $290,493 · Target: Indefinite

Rule 506(b)·1 investor·Section 4(a)(5)

May 14, 2024Form D — New notice

Reported sold: $110,000 · Target: $110,000

Rule 506(b)·1 investor·Section 4(a)(5)

Mar 20, 2024Form D — New notice

Reported sold: $142,200 · Target: $142,200

Rule 506(b)·1 investor·Section 4(a)(5)

Feb 12, 2024Form D — New notice

Reported sold: $457,470 · Target: $457,470

Rule 506(b)·1 investor·Section 4(a)(5)

Sep 12, 2023Form D/A — Amendment

Reported sold: $743,500 · Target: $743,500

Rule 506(b)·3 investors

Changed: Reported amount sold, Offering target, Sales commissions

Jul 28, 2023Form D — New notice

Reported sold: $225,000 · Target: $450,000

Rule 506(b)·3 investors

Jun 8, 2023Form D — New notice

Reported sold: $2,466,343 · Target: $2,466,343

Rule 506(b)·65 investors

Jun 8, 2023Form D — New notice

Reported sold: $1,339,781 · Target: $1,339,781

Rule 506(b)·41 investors

Oct 5, 2022Form D — New notice

Reported sold: $3,457,500 · Target: $20,000,000

Rule 506(b)·41 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

$889,250

Amendment Rate

10%

Latest reported sold across 27 identified offerings

$17,846,355

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Bret Barnes

Director

Appears on 24 filings

Francis Colt deWolf III

Director

Appears on 19 filings

Mark White

Executive Officer, Director

Appears on 19 filings

Martin Ward

Executive Officer

Appears on 19 filings

Trevor Langley

Related Person

Appears on 14 filings

Seamus Lagan

Related Person

Appears on 14 filings

Francis Colt deWolf III

Related Person

Appears on 6 filings

Bret Barnes

Related Person

Appears on 6 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Oct 14, 2025	Amendment	$3,500,000	$3,500,000	2
Oct 10, 2025	New	Indefinite	$600,000	2
Jun 20, 2025	New	$1,650,000	$1,650,000	1
Jun 2, 2025	New	$550,000	$550,000	1
May 22, 2025	New	$550,000	$550,000	1
Apr 21, 2025	New	$325,000	$325,000	1
Mar 24, 2025	New	$1,500,000	$110,000	2
Mar 21, 2025	Amendment	$1,650,000	$425,150	1
Mar 7, 2025	New	$98,900	$98,900	2
Mar 3, 2025	New	$55,000	$55,000	2
Feb 20, 2025	New	$120,000	$120,000	2
Feb 11, 2025	New	$110,000	$110,000	2
Feb 5, 2025	New	$150,650	$150,650	2
Jan 22, 2025	New	$291,500	$291,500	1
Jan 13, 2025	New	$5,000,000	$100,000	1
Dec 4, 2024	New	$220,000	$220,000	2
Dec 4, 2024	New	$220,000	$220,000	2
Oct 29, 2024	New	$40,533	$40,533	1
Oct 28, 2024	New	$256,500	$256,500	1
Oct 23, 2024	New	$121,900	$121,900	1
Aug 9, 2024	New	Indefinite	$290,493	1
Aug 9, 2024	New	Indefinite	$235,435	1
May 14, 2024	New	$110,000	$110,000	1
Mar 20, 2024	New	$142,200	$142,200	1
Feb 12, 2024	New	$457,470	$457,470	1
Sep 12, 2023	Amendment	$743,500	$743,500	3
Jul 28, 2023	New	$450,000	$225,000	3
Jun 8, 2023	New	$2,466,343	$2,466,343	65
Jun 8, 2023	New	$1,339,781	$1,339,781	41
Oct 5, 2022	New	$20,000,000	$3,457,500	41

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

PCFM Investments, LLC

Hospitals and Physicians

Offering target: $2,070,000

Filed Oct 28, 2026